Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists
about
A semi-quantitative RT-PCR method to measure thein vivo effect of dietary conjugated linoleic acid on porcine muscle PPAR gene expressionThe “Phantom Effect” of the Rexinoid LG100754: Structural and Functional InsightsBisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell lineIdentification of distant drug off-targets by direct superposition of binding pocket surfacesModulation of receptor phosphorylation contributes to activation of peroxisome proliferator activated receptor alpha by dehydroepiandrosterone and other peroxisome proliferatorsAllele-specific quantitative proteomics unravels molecular mechanisms modulated by cis-regulatory PPARG locus variation.The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis.Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells.Peroxisome proliferator-activated receptors in the cardiovascular system.Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot studyPPARA intron polymorphism associated with power performance in 30-s anaerobic Wingate Test.Conditional PPARγ knockout from cardiomyocytes of adult mice impairs myocardial fatty acid utilization and cardiac function.Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways.A human peripheral blood monocyte-derived subset acts as pluripotent stem cellsPPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationEffects of low doses of pioglitazone on resting-state functional connectivity in conscious rat brain.Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.Nuclear Receptors in Regulation of Mouse ES Cell Pluripotency and DifferentiationPPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone.The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsPPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsSuperparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes.Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy.Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.A Role for PPARbeta/delta in Ocular AngiogenesisPeroxisome proliferator-activated receptor gamma down-regulates follistatin in intestinal epithelial cells through SP1Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.Pathophysiological Roles of PPARgamma in Gastrointestinal Epithelial CellsThe possible role of peroxisome proliferator-activated receptor gamma in heart failure.Role of nuclear receptors in blastocyst implantation.Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.Peroxisome proliferator-activated receptors in diabetic nephropathy.Genetic analysis of four novel peroxisome proliferator activated receptor-gamma splice variants in monkey macrophages.Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity.The high affinity peroxisome proliferator-activated receptor-gamma agonist RS5444 inhibits both initiation and progression of colon tumors in azoxymethane-treated mice.The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancerCurrent understanding of the role of PPARγ in gastrointestinal cancers
P2860
Q24801673-3E8DD706-BC24-4641-B26C-52620655F37EQ27666286-19EF5B49-2C64-4D3E-B7AB-4F08E8E89DCBQ28344848-F644C27E-0083-4CD7-9E56-E77A8C71D488Q28538129-6551832A-7C55-4AB5-A409-A4DD11F6DCCBQ28564380-892166AC-F3DE-4620-8816-51C31B5C68DEQ33558410-A9C1BFBA-217C-49AC-8299-749E9B8ACBE4Q33712667-2FD5A7EF-DEE0-468B-B458-02EFE2D61937Q33815980-22F2A0F5-D024-4F17-9F41-F7683414B584Q33850995-752D9496-3F9A-473C-88F5-6245D9EE4B8DQ34122003-A9182A38-6077-4886-9D55-F7C75355469CQ34149893-55C50455-3EBE-4CE5-85AA-0388416BB46CQ34310253-ED28C1C0-7B8C-4332-AD7B-9CE054E3AE80Q34371949-A18DF030-E3F8-431D-A847-6B0FE1E6EB9BQ34805982-765DC618-DD9F-43E4-9C1A-CDD2B198A7B2Q35053566-21A32522-98EF-4C19-9F07-E8CB47379E14Q35073600-71580C89-043A-4A41-B608-3D502C9D55F3Q35125945-22ED9FCE-A341-4880-AF74-4ACA5ED8CB3FQ36445376-BBE12484-F2AC-489F-A780-D03C2E8A38D6Q36465006-6543E8E3-581A-4159-9733-B3C7D985DB68Q36465015-DCE9818E-EAED-4CC9-80B7-E97B6174FB3CQ36716822-D13D4F32-951F-44CD-9079-5BB6580FB7E8Q36733873-59FD280A-7FD2-43B0-BF2A-14D87BF224A2Q36859555-B49B62D1-D668-4987-8D3E-5B4C0F6DC465Q36998663-64FC9122-D31B-4531-8062-BE7F927C8DD8Q37029158-10285281-669A-49E7-B32F-6A7B286F3DAEQ37038408-CF0C6FB8-E0D0-447B-A066-00A0D2E89880Q37125975-2FF9E809-5593-4A6C-B13B-29990EECA148Q37142538-E1B19A5A-3DF7-484B-89F3-D5318648EEADQ37157531-6A5C661A-8034-4C83-ABDD-20F4F9FB2F61Q37166359-9A0AD0CF-D221-4930-9557-A1F55CA4C5D5Q37211826-41EF3D98-0140-4761-9BF7-F3A1CB2351F4Q37277818-F3D50FF1-741A-4980-9A0B-95AAB17C130CQ37361130-39CD3FAD-A276-4D17-ABD4-C29E4F848C06Q37377746-6C4BC35E-10BC-42A1-8F36-1A02FA6EC0DEQ37412297-609CC8C7-65AB-4EED-9BC9-1194DD101E51Q37417623-CEBF3104-F9DA-42FF-834A-829FCBA730AAQ37486151-C9EE001D-A234-4104-9DD7-4DFB89E6EE16Q37516766-610F9FFE-FD86-4F69-AA73-3B46705E5386Q37586958-C0C69932-42C9-42B8-95C3-D46775CDAA31Q37626440-F0FCB89F-ED0A-41B8-A73A-FEB0C5ABB1D2
P2860
Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists
description
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1997
@ast
im März 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/03/21)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/03/21)
@nl
наукова стаття, опублікована в березні 1997
@uk
name
Identification, characterizati ...... eptor agonists and antagonists
@ast
Identification, characterizati ...... eptor agonists and antagonists
@en
Identification, characterizati ...... eptor agonists and antagonists
@nl
type
label
Identification, characterizati ...... eptor agonists and antagonists
@ast
Identification, characterizati ...... eptor agonists and antagonists
@en
Identification, characterizati ...... eptor agonists and antagonists
@nl
prefLabel
Identification, characterizati ...... eptor agonists and antagonists
@ast
Identification, characterizati ...... eptor agonists and antagonists
@en
Identification, characterizati ...... eptor agonists and antagonists
@nl
P2093
P1476
Identification, characterizati ...... eptor agonists and antagonists
@en
P2093
G. E. Croston
J. R. Paterniti
R. Mukherjee
P304
P407
P577
1997-03-21T00:00:00Z